Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pulmicort

- PMLiVE

FDA queries safety of GSK’s Anoro for COPD

Adviser questions the drug's cardiovascular profile

- PMLiVE

Rigel plans job cuts in R&D restructure

Follows failure of fostamatinib disodium in rheumatoid arthritis trial

- PMLiVE

AZ’s olaparib enters phase III for ovarian cancer

Development of the drug had previously been halted in 2011

- PMLiVE

Meda buys US respiratory firm Acton in $200m deal

Swedish pharma firm gains access to asthma treatment Aerospan

- PMLiVE

AZ launches breast cancer video portal

Pharma company partners with oncology publisher for new HCP resource

UK preparing self-care portal for patients

Will replace NHS Choices as the 'digital front door' to health and social care

- PMLiVE

Rigel on the slide as asthma drug falls over

Share plummet after phase II failure of R343

- PMLiVE

Eisai launches online obesity awareness drive

Wants US employers to realise the cost of obesity

- PMLiVE

AZ adds to pipeline again with Amplimmune buy

Pharma company pays $500m via its MedImmune subsidiary for the small US biotech

- PMLiVE

Forest and Almirall delay FDA filing of COPD drug

Puts companies behind in LAMA/ LABA combination race

- PMLiVE

Understanding the post-digital world

The ubiquity of digital demands that pharmaceutical companies focus more closely than ever on finding out what their customers want

- PMLiVE

AZ inks $815m deal for FibroGen anaemia drug

Deal comes as company reveals second quarter performance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links